Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties.

Coulouarn, C; Factor, V M; Andersen, J B; Durkin, M E; Thorgeirsson, S S

Coulouarn, C; Factor, V M; Andersen, J B; Durkin, M E; Thorgeirsson, S S.

Affiliation

Coulouarn C; Laboratory of Experimental Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda 20892-4262, MD, USA.

Oncogene ; 28(40): 3526-36, 2009 Oct 08.

Article in En | MEDLINE | ID: mdl-19617899

Subject(s)

Carcinoma, Hepatocellular/genetics; Liver Neoplasms/genetics; MicroRNAs/physiology; Carcinoma, Hepatocellular/mortality; Carcinoma, Hepatocellular/pathology; Cell Line, Tumor; Gene Expression Profiling; Humans; Liver Neoplasms/mortality; Liver Neoplasms/pathology; MicroRNAs/analysis; Neoplasm Invasiveness; Neoplasm Metastasis; Phenotype; Prognosis

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Hepatocellular / MicroRNAs / Liver Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: Oncogene Journal subject: BIOLOGIA MOLECULAR / NEOPLASIAS Year: 2009 Type: Article Affiliation country: United States

Fulltext

XML

PubMed Links

Search on Google